GOP Lawmakers Push FDA to Diversify Clinical Trials

Republican lawmakers are pressing the incoming Trump FDA to enforce stricter diversity requirements for clinical trials. Their argument centers on ensuring drugs and devices actually work for all populations, not just a specific demographic. This policy shift could reshape how biomedical research is conducted in the US.